Screener
Amneal Pharmaceuticals, Inc. AMRX Goodwill
Goodwill at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Related party receivables | 424 | 470 |
| Total current assets | 1,947,029 | 1,911,181 |
| Property, plant and equipment, net | 456,877 | 442,950 |
| Goodwill | 593,499 | 595,470 |
| Intangible assets, net | 587,830 | 563,498 |
| Operating lease right-of-use assets | 44,361 | 38,832 |
| Operating lease right-of-use assets - related party | 13,723 | 15,216 |
| Financing lease right-of-use assets | 52,360 | 53,328 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Amneal Pharmaceuticals, Inc.'s goodwill?
- Amneal Pharmaceuticals, Inc. (AMRX) reported goodwill of $593.5M in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s goodwill changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s goodwill decreased by 0.7% year-over-year, from $597.41M to $593.5M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s goodwill?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s goodwill has grown at a 2.6% compound annual growth rate (CAGR), from $522.81M to $595.47M.
- What does goodwill mean?
- The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.
Ask your AI about Amneal Pharmaceuticals, Inc.'s goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude